VoxCell creates complex 3D printed models, bio-inks, and a high-resolution bioprinter to accelerate the development of life-saving anti-cancer drugs. Their biomimetic solutions, including vascularized cancer tissue models, help healthcare organizations reduce time and resources spent in pre-clinical trials and improve the testing of new therapies. Founded in 2020 and based in Victoria, Canada, VoxCell serves clients in the healthcare sector.